Blood Products Advisory Committee. Gaithersburgh, MD, September 14-15, 2000. Online at http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3649t1.rtf
2.
Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed. Blood safety in the new millennium. Bethesda, MD: American Association of Blood Banks, 2001. Pp. 33-54.
3.
Quality Systems. In: Vengelen-Tyler V, ed. Technical Manual. 13th ed.Bethesda, MD. American Association of Blood Banks, 1999. Pp. 1-36.
4.
Schüttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet2000;355(9197):41-42.
5.
Delwart E, Kalmin N, Jones S, Ladd D, Tobler L, Tsui R, Busch M. First case of HIV transmission by an RNA-screened blood donation. 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 24-28, 2002. (Abstract 768-W).
6.
Busch MP, Watanabe KK, Smith JW, Hermansen SW, Thomson RA. False-negative testing errors in routine viral marker screening of blood donors. For the Retrovirus Epidemiology Donor Study. Transfusion2000;40(5):585-589.
7.
Abstract in Transfus Clin Biol2001 June; 8 Suppl 1:198s.